Related references
Note: Only part of the references are listed.Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
Jaihwan Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2015)
Combined Detection of CEA, CA 19-9, CA 242 and CA 50 in the Diagnosis and Prognosis of Resectable Gastric Cancer
Shu-Bo Tian et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Identification of prognostic factors and surgical indications for metastatic gastric cancer
Yasuhiko Mohri et al.
BMC CANCER (2014)
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer
Mitsuro Kanda et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer
Xiao-tian Ye et al.
MEDICAL ONCOLOGY (2014)
Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer
Qing Wang et al.
MEDICAL ONCOLOGY (2014)
Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival
Fatma Paksoy Turkoz et al.
JOURNAL OF GASTRIC CANCER (2014)
Prognostic value of preoperative serum tumor markers in gastric cancer
Ze-Bo Huang et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer
Jae-Cheol Jo et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2013)
Impact of Various Tumor Markers in Prognosis of Gastric Cancer. A Hospital Based Study from Tertiary Care Hospital of Kathmandu Valley
Ankush Mittal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment
Fangxuan Li et al.
BIOMARKERS (2013)
Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
Todd M. Bauer et al.
CANCER (2013)
High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer
A. Ra Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer
X. Jiang et al.
BRITISH JOURNAL OF CANCER (2012)
Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination
Shigenobu Emoto et al.
GASTRIC CANCER (2012)
Prognostic significance of tumor markers in T4a gastric cancer
Xiaowen Liu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
The Relationships Between Perioperative CEA, CA 19-9, and CA 72-4 and Recurrence in Gastric Cancer Patients After Curative Radical Gastrectomy
Dae Hoon Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
PROGNOSTIC FACTORS IN PATIENTS WITH DIFFUSE TYPE GASTRIC CANCER (LINITIS PLASTICA) AFTER OPERATIVE TREATMENT
M. Schauer et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2011)
7th Edition of the AJCC Cancer Staging Manual: Stomach
Kay Washington
ANNALS OF SURGICAL ONCOLOGY (2010)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Prognostic Value of Preoperative CEA, CA 19-9, CA 72-4, and AFP Levels in Gastric Cancer
Edip Ucar et al.
ADVANCES IN THERAPY (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
XG Ni et al.
EJSO (2005)
Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors
CH Schmid et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Preoperauve hCGβ and CA 72-4 are prognostic factors in gastric cancer
J Louhimo et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Difference in prognostic value between sialyl Lewisa and sialyl Lewisx antigen levels in the preoperative serum of gastric cancer patients
T Nakagoe et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2002)
Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma
MJ Gaspar et al.
TUMOR BIOLOGY (2001)
The prognostic significance of preoperative sevum CA 19-9 in patients with resectable gastric carcinoma:: Comparison with CEA
N Duraker et al.
JOURNAL OF SURGICAL ONCOLOGY (2001)
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer
S Ishigami et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2001)
Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer
D Marrelli et al.
AMERICAN JOURNAL OF SURGERY (2001)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer
M Ychou et al.
DISEASE MARKERS (2000)
Share Paper
